Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2014

Oct 21, 2014

32939_dirs_2014-10-21_16a39816-dbb6-42c7-ac76-0bc359b4d477.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2014-10-20

Reporting Person: Greiner Charles R (VP - Global Franchise)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-10-20 Common Stock S 3298 $15.63 Disposed 22055 Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.58 to $15.665, inclusive. The reporting person undertakes to provide to AngioDynamics, Inc., any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.